1 unchanged sentence
The information required by Item 201 of Regulation S-K is contained in ‘‘ Item 1.
−Removed: On August 25, 2021, our Board made a grant to our directors and CEO, entitling them to receive an aggregate of 68,834 Common Shares which shall not be issued to the award recipients unless certain time or performance based vesting criteria, as applicable, are met, in which case the vesting will occur in equal parts over a three-year period.
+Added: On April 6, 2022 and December 31, 2022, our Board made grants to our directors and employees, entitling them to receive an aggregate of 89,925 common shares and 43,096 common shares, respectively, which shall not be issued to the award recipients unless certain time or performance based vesting criteria, as applicable, are met, in which case the vesting will occur in three equal parts on the succeeding periods ending on December 31.
+Added: On July 1, 2022, our Board made grants to a director of 18,000 common shares, and to our new CEO and CFO, entitling them to receive an aggregate of 138,210 common shares which shall not be issued to the award recipients unless certain time or performance based vesting criteria, as applicable, are met, in which case the vesting will occur in equal parts over a three-year and four-year period, respectively.
The awards were made under the 2020 Equity Incentive plan in accordance with Rule 701 promulgated under the Securities Act.
−Removed: Commencing on January 1, 2021, the Company entered into a share repurchase program on the NASDAQ conducted in accordance with Rule 10b-18 promulgated under the Securities Exchange Act of 1934.
−Removed: The Company was authorized to repurchase up to 1,193,000 of its outstanding common shares, representing 5% of the outstanding common shares of Epsilon as of January 1, 2021.
−Removed: The program ended December 31, 2021 and the shares were subsequently cancelled.
−Removed: Repurchases were made at management’s discretion from time to time through the facilities of the NASDAQ Global Market.
−Removed: The price paid for the common shares was, subject to applicable securities laws, the prevailing market price of such common shares on the NASDAQ Global Market at the time of such purchase.
+Added: Commencing on March 8, 2022, the Company entered into a share repurchase program conducted in accordance with Rule 10b-18 promulgated under the Exchange Act.
+Added: The Company was authorized to repurchase up to 1,183,410 of its outstanding common shares, representing 5% of the outstanding common shares of the Company as of February 24, 2022.
+Added: The program ended on March 7, 2023.
The Company funded the purchases out of available cash and did not incur debt to fund the share repurchase program.
−Removed: The shares are accounted for as treasury shares until such a time as they are cancelled.
−Removed: The following table contains information about our repurchase of equity securities during the year ended December 31, 2021:
−Removed: Maximum number
−Removed: of shares that
−Removed: Average price
−Removed: purchased under
−Removed: Beginning of normal-course issuer bid, January 1, 2021
−Removed: January 2021 (1)
−Removed: February 2021 (1)
−Removed: March 2021 (1)
−Removed: April 2021 (1)
−Removed: June 2021 (1)
−Removed: July 2021 (1)
−Removed: August 2021 (1)
−Removed: September 2021 (1)
−Removed: October 2021 (1)
−Removed: November 2021 (1)
−Removed: December 2021 (1)
−Removed: Total as of December 31, 2021
−Removed: (1) Epsilon repurchased these shares under its share repurchase program that commenced on January 1, 2021, as described above.
+Added: The shares are accounted for as treasury shares until such a time as they are retired.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.